NCAPH2 and Alzheimer disease: Methylation of several genes have been proposed as potential early biomarkers of AD, including RPL13, KLOTHO, SORL1, NCAPH2/LMF2, BDNF, OXT, COASY, APOE, BIN1 and PM20D1 (Table 1).